S. Tang

发表

D. Helmeste, S. Tang, 2000, Japanese journal of pharmacology.

Effects of amoxapine and imipramine on evoked potentials in the Continuous Performance Test in patients with affective disorder.

M. Buchsbaum, R. Haier, J. Wu, 1988, Neuropsychobiology.

Inhibition of platelet [3H]-imipramine binding by human plasma protein fractions.

S. Tang, J. Chudzik, A. Strijewski, 1988, Life sciences.

Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets.

D. Helmeste, S. Tang, C. Reist, 1995, European journal of pharmacology.

Neuroprotection in steroid therapy: a rodent model.

S. Tang, K. So, T. M. Lee, 2012, Hong Kong medical journal = Xianggang yi xue za zhi.

A three-month, open-label, single-arm trial evaluating the safety and pharmacokinetics of oral lithium in patients with chronic spinal cord injury

W. Young, S. Tang, K. Luk, 2011, Spinal Cord.

Temperature-sensitive reversible loss of [3H]imipramine binding sites: evidence suggesting different conformational states.

S. Tang, A. Davis, J. Morris, 1983, European journal of pharmacology.

Temperature-sensitive conformational changes in membrane-bound and solubilized [3H]imipramine binding sites.

S. Tang, A. Davis, J. Morris, 1983, European journal of pharmacology.

Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol.

D. Helmeste, S. Tang, H. Stancer, 1979, Canadian journal of physiology and pharmacology.

Manipulations of synaptic serotonin: discrepancy of effects on serotonin S1 and S2 sites.

S. Tang, A. Dumbrille-Ross, 1983, Life sciences.

Differential binding of 3H-imipramine and 3H-mianserin in rat cerebral cortex.

S. Tang, D. Coscina, A. Dumbrille-Ross, 1981, Life sciences.

Protective effects of EUK4010 on β‐amyloid(1–42) induced degeneration of neuronal cells

S. Tang, Yinghe Hu, Yong Sun, 2006, The European journal of neuroscience.

CNS 3-methoxy-4-hydroxyphenylglycol: Its peripheral assessment by isotopic dilution and theoretical significance

S. Tang, J. Warsh, H. Stancer, 1978, Brain Research Bulletin.

The role of calcium in the etiology of the affective disorders.

D. Helmeste, S. Tang, 1998, Japanese journal of pharmacology.

The effect of acute and chronic desipramine and amitriptyline treatment on rat brain total 3methoxy-4-hydroxyphenylglycol.

D. Helmeste, S. Tang, H. Stancer, 1978, Naunyn-Schmiedeberg's archives of pharmacology.

Absence of high-ffinity [3H]imipramine binding in platelets and cerebral cortex of fawn-hooded rats.

S. Tang, A. Dumbrille-Ross, 1981, European journal of pharmacology.

Conversion of bromperidol to reduced bromperidol in human liver.

R. Tyndale, S. Tang, T. Someya, 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Depression Associated with Cimetidine

S. Tang, V. Rakoff, R. F. Billings, 1981, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Multiple [3H]-nemonapride binding sites in calf brain

Ming Li, D. Helmeste, S. Tang, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Prediction of treatment response in schizophrenia: clinical use of neuroleptic blood levels.

S. Tang, 1985, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).

S. Tang, A. Davis, J. Morris, 1985, European journal of pharmacology.

Haloperidol reduction can be assayed in human red blood cells.

S. Tang, T. Someya, W. Kalow, 1989, Canadian journal of physiology and pharmacology.

Inhibition of platelet serotonin uptake by cytochrome P450 inhibitors miconazole and econazole.

D. Helmeste, S. Tang, R. Vu, 1998, Life sciences.

Kinase inhibitors compete with imipramine for binding and inhibition of serotonin transport.

D. Helmeste, S. Tang, 1994, European journal of pharmacology.

Binding of [3H]U-101958 to sigma1 receptor-like sites in human cerebellum and neuroblastoma cells.

D. Helmeste, S. Tang, M. Mitsuhashi, 1999, European journal of pharmacology.

Temperature-sensitive high affinity [3H]serotonin binding: characterization and effects of antidepressant treatment.

D. Helmeste, S. Tang, 1984, Life Science.

Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors.

D. Helmeste, S. Tang, 1983, Life sciences.

Solubilization and assay of [3H]imipramine binding sites from human platelets.

S. Tang, A. Davis, J. Morris, 1983, European journal of pharmacology.

Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.

E G Jones, W. Bunney, D. Helmeste, 1996, European journal of pharmacology.

Brain sigma receptors labelled by [3H]nemonapride.

D. Helmeste, S. Tang, M. Li, 1996, European journal of pharmacology.

Preparation and characterization of anti-paroxetine antibodies.

S. Tang, A. Strijewski, 1990, Life sciences.

Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.

S. Tang, A. Dumbrille-Ross, 1983, Molecular pharmacology.

Tyrosine kinase inhibitors regulate serotonin uptake in platelets.

D. Helmeste, S. Tang, Siu Wa Tang, 1995, European journal of pharmacology.

Interaction of lectins with human platelet serotonin transporter.

D. Helmeste, S. Tang, J. Chudzik, 1994, European journal of pharmacology.

Relevance of polymorphic drug oxidation in the use of neuroleptics in schizophrenia.

S. Tang, 1986, Progress in clinical and biological research.